Activity of radium-223 therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) as third line therapy

2019 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []